Global bioreactors market is expected to reach to USD 1,417 Million by 2021 from USD 955 Million in 2015, at a CAGR of 6.8% between 2015 and 2021

The objective of this report is to identify various end-users, usage, scale, material, control types and suppliers of bioreactors market. It involves an in-depth volume market analysis of these different segments covered. The report also provides a deep insight into the strategies of key players of the market. The report also provides a detailed competitive landscaping of companies operating in this market. News & Deals, M&A, product approvals and product recalls of the major companies would be detailed.

This research study involved the use of extensive secondary sources, directories, and databases, such as Hoovers, Bloomberg Business, Factiva, and Avention, to identify and collect information useful for this technical, market-oriented, and commercial study of the global bioreactor market. Primary sources are mainly industry experts from core and related industries and preferred suppliers such as Original Equipment Manufacturers (OEMs), Engineering Procurement Construction (EPCs), and end-users such R&D departments and biopharmaceutical manufacturers related to all segments of this industry’s value chain.

In-depth interviews were conducted from various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess future prospects. The following illustrative figure shows the market research methodology applied in making this report on the global bioreactor market.

This report categorizes the bioreactor volume market on the basis of end-users, usage, scale, material, control types and suppliers.

Market Segmentation, By End-Users: Based on end-user, the bioreactor market has been segmented into

R&D Departments

R&D Institutes

CROs (Contract Research Organizations)

Biopharmaceutical Companies

Biopharmaceutical Manufacturers

CMOs (Contract Manufacturing Organizations)

Biopharmaceutical Companies

Market Segmentation, By Usage: Based on Usage, the bioreactors market has been segmented into

Lab-Scale Production

Pilot-Scale Production

Full-Scale Production

Market Segmentation, By Scale (In Liters): The scale analysis covers

5L-20L

20L-200L

200L-1500L

Above 1500L

Market Segmentation, By Material: Based on Material, the bioreactors market has been segmented into

Glass

Stainless Steel

Single-Use

Market Segmentation, By Control Type: The control type analysis covers

Manual

Automated (MFCs)

Market Segmentation, By Suppliers: The supplier analysis covers

Original Equipment Manufacturers (OEMs)

System Integrators

Engineering Procurement and Construction (EPCs)

Customization Options:

Along with market data, customize the MNM assessments to meet your company’s specific needs. Customize to get a comprehensive summary of the industry standards and a detailed analysis of the following parameters: product analysis, brand/product perception matrix, porters five force’s analysis, regulatory framework, and competitive intelligence.

The global bioreactors market is expected to reach to USD 1,417 Million by 2021 from USD 955 Million in 2015, at a CAGR of 6.8% between 2015 and 2021. The increase in adoption of single-use technologies, use of hybrid technologies: single-use and stainless steel, growing popularity of single-use bioreactor among biopharmaceutical companies, and growing biologics are spurring the growth of the bioreactors market. However, regulatory concerns related to single-use bioreactors, issues regarding leachable and extractable related to single-use bags is hampering the growth of this market.

The global bioreactor market is segmented on the basis of end-users, usage, scale, material, control types and suppliers. Furthermore, the geographic analysis covers North America, Europe, Asia-Pacific, and Rest of the World (RoW).

On the basis of end-user, the bioreactor market has been segmented into R&D departments and biopharmaceutical manufacturers. The R&D departments segment is expected to register the highest growth rate from 2016 to 2021 owing to increased bioreactor usage in process development. Contract manufacturing organizations (CMOs) on the other hand are expected to gain traction in the coming years due to rise in outsourcing needs for biologics manufacturers as a result of increased demand of biologics.

By material, single-use bioreactors are expected to register second highest growth by volume during the forecast period from 2016 to 2021. High growth in this segment is attributed to the advantages of SUBs such as reduced need for cleaning and sterilization, reduced risk of cross contamination, and greater control over aseptic conditions.

Bioreactors are mainly used for growing organisms such as bacteria or yeast that are used in the biotechnological production of substances such as pharmaceuticals, antibodies, and vaccines or for bioconversion of organic waste. By usage, it is segmented into lab-scale, pilot-scale and full-scale production. The lab-scale production segment will witness maximum growth by volume from 2016 to 2021, owing to process development in R&D departments.

By control type, the bioreactor market is segmented into manual and automated control type. In 2015, in terms of volume, the automated control type segment accounted for the largest share of the bioreactors market. In the present scenario, the preference for mass flow controllers (MFCs) is growing, resulting into usage of automated control type. This is because they add additional security assurance and reduce the operating costs of bioreactors. Running bioreactors on MFCs does not require skilled labour. As a result, an increasing number of companies are opting for MFCs.

By suppliers, the market is segmented into Original Equipment Manufacturers (OEMs), system integrators and Engineering Procurement and Construction (EPCs). OEMs not only supply the equipment but also set up the piping and integration, instrumentation, programing, and control. In 2015, OEMs accounted for the larger market share compared to EPCs.

The North American region accounted for the largest share in the bioreactors market in 2016. One of the main factors contributing to this large share is the increase in number of biomanufacturing facilities and investments in this region. Government in North American countries actively supports the biologics production by providing funds to life science R&D.

The bioreactors market is a competitive market with a large number of companies operational in the market. The competitive landscape includes an in-depth market share analysis along with the key business strengths of leading players in the market. Some of the leading players offering bioreactor products are Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (U.S.), Merck KGaA (Germany), GE Healthcare (A subsidiary of General Electric Company) (U.S.), Danaher Corporation (U.S), Eppendorf AG (Germany).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.